Companies related to Immuno-oncology

Bringing context to biology and human health through spatial phenotyping — we are The Spatial Biology Company®. 🥼🧬

Conquering Cancer

Biond - Innovative immunotherapies and a pioneering intracellular delivery for biologics for the treatment of patients

This page is no longer active. Please follow us at Labcorp Drug Development.

In Pursuit of Answers

Genomics for better health

Leading, late clinical-stage nanomedicine company pioneering new approaches to significantly change patient outcomes.

The Eurofins Discovery Products Company

A clinical-stage cancer immunotherapy company and a pioneer in computational target discovery

LEADING THE WAY FROM BASIC TO APPLIED INNOVATIVE RESEARCH

LEADING THE WAY FROM BASIC TO APPLIED INNOVATIVE RESEARCH

We are in the business of extending life for patients.

Developing Innovative Cell Therapies Against Cancer

Founded in 1953, CRI is the world's leading nonprofit dedicated to funding cancer immunotherapy research.

Leading a new way to fight cancer

Personalizing Precision Oncology

We’re revolutionizing #cancercare through #IL2 therapeutics designed to direct the #immunesystem to destroy cancers.

Oncology company developing Biclonics® bispecific antibody therapeutics. See our Community Guidelines: http://bit.ly/36c

Unlocking the future of medicine

Decoding Biology to Radically Improve Lives

A Member of the Roche Group

Let's Build Better Cells Together

Transcend The Conventional

Improving patient outcomes with AI-powered pathology.

Harnessing Innate and Adaptive Immune Responses to Cure Disease.

Great Science Deserves Great People.

Creating neoantigens by design -- to transform cancer treatments into cures

Pioneer in living medicines

A preclinical-stage biotech focusing on oncology and immunology

Novel human immunomodulatory proteins for cancer and autoimmune diseases with a specific role in innate immunity

Smart Clinical Operations. Tailored partnerships. Real results.

Bringing Effective New Treatments And Options To Patients Who Need Them

A new frontier in the fight against cancer– the right activation of the right immune cells

Fate can be altered.

Any Assay, Anywhere, Any Area. A Global Leader for Services in Drug R&D Enabling.

Agilex Biolabs is Australia’s Largest and Most Technologically Advanced Biolab with Global Reach

Advancing Immunotherapy with Novel Antigen Discovery

#biopharma #biotech #drugdiscovery #GPCR #Immunooncology #inflammation

Unlocking targeted medicines with our transformative mRNA platform

Best-in-class treatment of HPV-cancer

Targeted delivery of nanoparticles for in vivo CAR T therapy

Developing a portfolio of immune-educating therapies based on our DPX® platform to treat solid and hematologic cancers

From promising to validated immuno-therapeutics: GEM design and humanization, profiling solutions for your candidate

Attacking Bladder Cancer for a Better Tomorrow

"Turn breakthroughs into success with Snow Leopard Consulting's innovative, cost-effective preclinical solutions." ©️

Pioneering A New Class of Universal Vaccines

Iovance is a patient-centric, collaborative organization that is driven to change the way cancer is treated.

Pioneering thymus-empowered T-cell platform to fight cancer and infection

Human translational data early - We help you bridge the safety and dosing gap between pre-clinical & clinical studies

Engineered Immunity

We provide drug developers with high-quality data to give them the confidence to take their drug discovery forward.

New therapies for inflammatory disease and cancer by targeting fibroblast immunology

Powering the next generation in bioelectric medicine with Nanosecond Pulsed Field Ablation technology.

At your side to pioneer immuno-oncology therapies

Supercharging Immunotherapy

Accelerating Drug Development with R&D Services Driven by Science and Technology

We are developing next-generation antibodies into transformative cancer therapies that improve patients’ lives.

A fully integrated biotech company at the forefront of pioneering cutting-edge immunotherapies.

is developing disruptive therapies to address critical unmet medical needs in cancer and infectious diseases.

Saving Lives Through Innovation

AI-powered precision diagnostics for pathology

Pioneering DARPin Therapeutics for Patients

A leading Immuno Oncology company in the space of NK cell therapeutics

REDEFINING ANTIBODY THERAPIES

On a quest to leverage the power of single cell genomics to discover novel drug targets and precision therapeutics.

Macrophage Biology Revealed:Developing breakthrough approaches to macrophage activity to change the course of disease

Our expertise, Your discovery

Innovative clinical trial solutions

evaxion.ai

Developing Biotechnology Solutions That Transforms Lives | Clinical Research | Bioanalytical & Drug Development

We are in the business of extending life for patients.

Engineering the future of targeting Natural Killer off-the-shelf cell therapy against cancer.

Virotherapy to Ignite Immunotherapy

We understand disease through the lens of the immune system for more effective, safer treatments & better diagnosis.

A specialty oncology CRO and a pioneer in immunotherapy studies.

Developing transformative medicines in neuroscience using artificial intelligence approaches

Deep Immune Phenotyping & MultiOmics DataScience, for immune precision medicine

ImmuNext develops compounds on the cutting edge of immunotherapy for cancer and autoimmune diseases.

Committed to delivering effective TCR cancer therapies. Striving towards a cure.

Your key partner for breakthrough antibody discovery

An off-the-shelf multimodal biological immunotherapy company empowering the patient's immune system to fight cancer.

Harnessing the Power of Natural Killer Cells

Discover the Hidden Variables that Predict Patient Response

Clinical-stage biotech company developing drugs that harness glyco-immunology to treat cancer and inflammatory diseases

Your partner in immunology projects!

Discovering drugs that create neoantigens

An advanced-clinical-stage biotechnology company developing dendritic cell therapies to treat cancer

MAKING THE INVISIBLE VISIBLE IN THE FIGHT AGAINST CANCER

The KREX™ platform delivers precision antibody profiling with correctly folded, highly multiplexed proteins.

A global leader in bispecific antibody therapeutics for immuno-oncology and neurodegenerative diseases.

TiumBio is committed to developing innovative therapeutics for patients with rare or incurable diseases

Visibility to Immuno-Oncology & Lymphocyte Enhancing Therapies

Driven by Immunology in the Pursuit of Powerful Prevention and Treatment of Disease

We transform lives by inspiring science & leading innovation.

Maximizing immune integrity through the development of unique natural killer (NK) cell therapies.

Altevax is developing a disruptive immunotherapy technology against cancer